Triomics is a generative AI platform purpose-built for oncology workflows. The company offers solutions to help in trial enrollment, improve quality of care, and assist in healthcare operations by using artificial intelligence to interpret health records and medical terminology.
Tip: The CEO isn't always your best path in. Data Surfer finds the champions and influencers who actually drive purchasing decisions.
| Ownership Private Company |
| Funding $28.9M |
Triomics is a generative AI platform purpose-built for oncology workflows that helps cancer centers interpret health records and medical terminology to improve trial enrollment and quality of care.
Triomics operates as a provider of clinical research and clinical trial tracking software, primarily serving the healthcare sector and oncology care providers.
Get qualified leads in 10 minutes. Research prospects, find decision makers, and monitor for the perfect moment to reach out.
Last verified: February 2, 2026
Connect with Triomics